Interventions for preventing bone disease in kidney transplant recipients

Area of Science:

• Nephrology
• Endocrinology
• Orthopedics

Background:

• Kidney transplant recipients have significantly higher fracture risks due to bone remodeling and mineral homeostasis abnormalities.
• This risk is notably greater than in the general population or dialysis patients.

Purpose of the Study:

• To evaluate the effectiveness of interventions for treating bone disease in kidney transplant recipients.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) and quasi-RCTs.
• Searched multiple databases including Cochrane CENTRAL, MEDLINE, and EMBASE up to May 2006.
• Data extraction and quality assessment by two independent reviewers; random effects model used for analysis.

Main Results:

• No single intervention (bisphosphonates, vitamin D sterols, calcitonin) reduced fracture risk versus placebo individually.
• Combined active interventions showed a reduction in fracture risk (RR 0.51, 95% CI 0.27 to 0.99).
• Bisphosphonates, vitamin D sterols, and calcitonin improved bone mineral density at the lumbar spine; bisphosphonates and vitamin D sterols also benefited the femoral neck.

Conclusions:

• Bisphosphonates, vitamin D sterols, or calcitonin may help prevent bone density loss and fractures post-transplant.
• Further large-scale trials are necessary to compare bisphosphonates directly with vitamin D sterols for fracture prevention.
• Optimal administration strategies (route, timing, duration) for these treatments remain undetermined.